Twist Bioscience (TWST) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket
 
Twist Bioscience Corporation  (NASDAQ: TWST)

Select the Financial Report: Select the Period:


Description of Twist Bioscience's Business Segments


Twist Bioscience Corporation is a prominent player in the biotechnology landscape, specializing in the design and synthesis of synthetic DNA. The company operates across multiple segments, with a diverse portfolio of products and services aimed at researchers, biopharma clients, and agricultural stakeholders. Below is an extensive description of the segments, products, and services offered by Twist Bioscience:

Segments

1. Synthetic Biology
This segment focuses on the creation and utilization of synthetic DNA across various applications. As a leader in synthetic biology, Twist Bioscience provides vital resources for:
- Academic Research: Facilitating fundamental studies in genetics, molecular biology, and bioengineering.
- Gene Therapy: Developing synthetic DNA for therapeutic applications targeting genetic disorders.
- Drug Development: Assisting pharmaceutical companies in the rapid development of new therapeutic compounds.
- Agricultural Biotechnology: Supporting advancements in crop genetics to enhance yield, resistance, and sustainability.
- Industrial Biotechnology: Exploiting synthetic biology for creating enzymes and other biotechnology products used in industrial processing.

Biopharma
The biopharma segment caters to organizations involved in drug development and therapeutics. Important offerings in this segment include:
- Synthetic Antibodies: Providing cutting-edge solutions for the identification and production of therapeutic antibodies.
- Gene Editing Technologies: Enabling precise modifications to genetic material to expedite drug discovery and development processes.
- Oligonucleotide Therapeutics: Focusing on developing therapeutic solutions utilizing synthetic nucleotides for conditions that are not adequately addressed by existing therapies.

Products

1. DNA Synthesis
Twist Bioscience revolutionizes custom DNA synthesis through its proprietary technology that allows for:
- Custom Oligonucleotides: Tailored short DNA sequences tailored to specific research needs.
- Gene Fragments: Custom segments of DNA that can be used in various applications including cloning, expression, or functional studies.
- Complete Gene Synthesis: The capability to synthesize entire genes, enabling researchers to build complex genetic constructs.

Synthetic Antibodies
Leveraging its synthetic biology platform, Twist Bioscience provides:
- Fully Human Monoclonal Antibodies: Professionally designed antibodies for research and therapeutic applications.
- Custom Antibody Pairs: Offering specialized pairs tailored for specific research applications.
- Antibody Libraries: Extensive collections of antibodies that can be screened to identify candidates for therapeutics.

Gene Editing Tools
These tools facilitate efficient manipulation of DNA, providing:
- CRISPR-based Technologies: Technologies that enable precise edits within genomic DNA to create models for studying diseases or developing therapies.
- Gene Knock-in and Knock-out Solutions: Delivering mechanisms for either inserting or disabling genes in various organisms for research purposes.

Services

1. DNA Data Storage
Using innovative synthetic DNA technology, Twist Bioscience provides an alternative method for:
- Data Encoding and Storage: Transforming digital data into synthetic DNA, allowing for the storage of vast amounts of information in a compact, durable medium.
- Data Retrieval: Developing methods to access and decode stored information efficiently, paving the way for future data storage needs.

Genomics and Next Generation Sequencing (NGS)
Twist Bioscience is at the forefront of sequencing technologies by offering:
- High-Throughput Sequencing Services: Employing advanced technologies to deliver accurate genomic data for research purposes.
- Targeted Sequencing Solutions: Providing focused sequencing services for specific regions of the genome to enhance research efficiency.

Animal Health
Twist Bioscience extends its offerings into the agricultural sector with services designed for livestock and breeding:
- Custom Breeding Solutions: Tailored genetic solutions to enhance traits in livestock to support health and productivity.
- Livestock Genotyping Services: Delivering precise genetic information about animal populations to inform breeding decisions and improve herd management.

Conclusion
Overall, Twist Bioscience Corporation stands out in the biotechnology arena for its commitment to innovation, efficiency, and the advancement of synthetic biology applications. By providing a comprehensive suite of products and services across various segments, the company plays a crucial role in enhancing human health, agricultural productivity, and industrial biotechnology solutions, thereby contributing positively to society and the environment.


Composition of Twist Bioscience Corporation Revenues by Segments

 
Americas    58.08 % of total Revenue
EMEA    33.73 % of total Revenue
APAC    8.18 % of total Revenue
DNA synthesis and protein solutions    48.12 % of total Revenue
NGS applications    51.88 % of total Revenue
Therapeutics    36.82 % of total Revenue
Diagnostics    36.09 % of total Revenue
Industry and applied    5.24 % of total Revenue
Academic research and government    11.58 % of total Revenue
Global supply partners    10.28 % of total Revenue
Reportable Segment    100 % of total Revenue

Q2 three months ended (Mar 31 2026)
Revenues by Business Segments Revenues
(in millions $)
%
(of total Revenues)
Americas 64.31 58.08 %
EMEA 37.35 33.73 %
APAC 9.06 8.18 %
DNA synthesis and protein solutions 53.27 48.12 %
NGS applications 57.44 51.88 %
Therapeutics 40.77 36.82 %
Diagnostics 39.96 36.09 %
Industry and applied 5.80 5.24 %
Academic research and government 12.82 11.58 %
Global supply partners 11.38 10.28 %
Reportable Segment 110.72 100 %
Total 110.72 100 %




Q2 three months ended (Mar 31 2026)
Revenue Growth rates by Segment Y/Y Revenue
%
Q/Q Revenue
%
Americas 16.52 % 10.15 %
EMEA 21.88 % -2.65 %
APAC 30.15 % 30.34 %
DNA synthesis and protein solutions 27.92 % 4.34 %
NGS applications 12.31 % 9.12 %
Therapeutics 55.3 % 9.51 %
Diagnostics 14.07 % 13.15 %
Industry and applied -17.69 % -5.29 %
Academic research and government 2.78 % 4.9 %
Global supply partners -5.21 % -11.26 %
Reportable Segment 19.31 % 6.77 %
Total 19.31 % 6.77 %




Q2 three months ended (Mar 31 2026)
Income by Business Segments Income
(in millions $)
%
(Profit Margin)
Reportable Segment -45.86 -
Total -44.02 -




Q2 three months ended (Mar 31 2026)
Income Growth rates by Segment Y/Y Income
%
Q/Q Income
%
Reportable Segment - -
Total - -




Annual Report on Twist Bioscience Corporation Divisions, Sales by Country

 
Americas   Americas Segment contribution to total sales 59.9 % of total Revenue
EMEA   EMEA Segment contribution to total sales 32.99 % of total Revenue
APAC   APAC Segment contribution to total sales 7.1 % of total Revenue
Reportable Segment   Reportable Segment Segment contribution to total sales 100 % of total Revenue
Synthetic genes   Synthetic genes Segment contribution to total sales 30.17 % of total Revenue
Oligo pools   Oligo pools Segment contribution to total sales 5.37 % of total Revenue
DNA libraries   DNA libraries Segment contribution to total sales 2.97 % of total Revenue
Antibody discovery   Antibody discovery Segment contribution to total sales 6.23 % of total Revenue
NGS tools   NGS tools Segment contribution to total sales 55.26 % of total Revenue
Industrial chemicals materials   Industrial chemicals materials Segment contribution to total sales 24.76 % of total Revenue
Academic research   Academic research Segment contribution to total sales 17.49 % of total Revenue
Healthcare   Healthcare Segment contribution to total sales 57.12 % of total Revenue
Food agriculture   Food agriculture Segment contribution to total sales 0.63 % of total Revenue


Twelve months ended 2025
TWST s Annual Revenue by Geography and Business Segments Sales
(in millions $)
%
(of total Sales)
Americas 225.58 59.9 %
EMEA 124.24 32.99 %
APAC 26.75 7.1 %
Reportable Segment 376.57 100 %
Total 376.57 100 %
Synthetic genes 113.60 30.17 %
Oligo pools 20.23 5.37 %
DNA libraries 11.18 2.97 %
Antibody discovery 23.45 6.23 %
NGS tools 208.10 55.26 %
Industrial chemicals materials 93.25 24.76 %
Academic research 65.86 17.49 %
Healthcare 215.09 57.12 %
Food agriculture 2.37 0.63 %


Twelve months ended 2025
TWST s Annual Income by Country and Business Segments Income
(in millions $)
%
(Profit Margin)
Reportable Segment -136.26 -
Total -77.67 -

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth
Americas 16.35 % -
EMEA 34.22 % -
APAC 0.86 % -
Reportable Segment 20.32 % -
Total 20.32 % -
Synthetic genes 22.58 % -
Oligo pools 19.66 % -
DNA libraries -19.73 % -
Antibody discovery 15.37 % -
NGS tools 23.05 % -
Industrial chemicals materials 11.71 % -
Academic research 12.68 % -
Healthcare 27.3 % -
Food agriculture 13.49 % -



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.